Editorial: Benefits and risks of agonist triggering strategies
2024
Benefits and Risks of Agonist Triggering Strategies
Editorial
Author Information
Author(s): Jan Tesarik
Primary Institution: MARGen Clinic, Granada, Spain
Conclusion
The data presented support the inclusion of GnRHa and GnRHant in controlled ovarian stimulation protocols.
Supporting Evidence
- The use of GnRH analogues simplifies ovarian stimulation protocols and reduces the risk of ovarian hyperstimulation syndrome.
- Clinical practice has not substantiated initial concerns about GnRH analogues interfering with early pregnancy.
- Data from various studies support the efficacy and safety of GnRHa and GnRHant in assisted reproduction.
Takeaway
This article discusses how certain medications can help with fertility treatments and whether they are safe to use during pregnancy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website